These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2474511)

  • 1. Decreased releasability of basophils from patients with cold urticaria after cold exposure.
    Hessler HJ; Pufahl C; Christophers E
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):236-41. PubMed ID: 2474511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria.
    Kikuchi Y; Kaplan AP
    J Allergy Clin Immunol; 2002 Jan; 109(1):114-8. PubMed ID: 11799375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction.
    Siraganian RP; Hook WA
    J Immunol; 1976 Mar; 116(3):639-46. PubMed ID: 56398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 3-dependent mediator release in basophils triggered by C5a.
    Kurimoto Y; de Weck AL; Dahinden CA
    J Exp Med; 1989 Aug; 170(2):467-79. PubMed ID: 2474054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.
    Schulman ES; Post TJ; Henson PM; Giclas PC
    J Clin Invest; 1988 Mar; 81(3):918-23. PubMed ID: 2449462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basophil "releasability" in patients with asthma.
    Findlay SR; Lichtenstein LM
    Am Rev Respir Dis; 1980 Jul; 122(1):53-9. PubMed ID: 6157344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basophil function in patients with chronic myelogenous leukaemia.
    Lett-Brown MA; Juneja HS
    Br J Haematol; 1985 Dec; 61(4):621-6. PubMed ID: 2417616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and release of platelet-activating factor (PAF) from enriched preparations of rabbit basophils; failure of human basophils to release PAF.
    Betz SJ; Lotner GZ; Henson PM
    J Immunol; 1980 Dec; 125(6):2749-55. PubMed ID: 6159420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli.
    Warner JA; Peters SP; Lichtenstein LM; Hubbard W; Yancey KB; Stevenson HC; Miller PJ; MacGlashan DW
    J Leukoc Biol; 1989 Jun; 45(6):558-71. PubMed ID: 2470847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli.
    Luquin E; Kaplan AP; Ferrer M
    Clin Exp Allergy; 2005 Apr; 35(4):456-60. PubMed ID: 15836753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of autoimmune activation of basophils in chronic urticaria.
    Kikuchi Y; Kaplan AP
    J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin enhances in vitro histamine release induced by anti-IgE and Ca-ionophore but inhibits C5a-induced release reactions from basophils of atopics and normals.
    Ring J; Walz U
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):225-7. PubMed ID: 2409022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
    Vonakis BM; Vasagar K; Gibbons SP; Gober L; Sterba PM; Chang H; Saini SS
    J Allergy Clin Immunol; 2007 Feb; 119(2):441-8. PubMed ID: 17125820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pertussis toxin on mediator release from human basophils.
    Warner JA; Yancey KB; MacGlashan DW
    J Immunol; 1987 Jul; 139(1):161-5. PubMed ID: 2438348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basophils activation of patients with chronic spontaneous urticaria in response to C5a despite failure to respond to IgE-mediated stimuli.
    Matsubara D; Yanase Y; Ishii K; Takahagi S; Tanaka A; Ozawa K; Hide M
    Front Immunol; 2022; 13():994823. PubMed ID: 36248902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
    el-Lati SG; Dahinden CA; Church MK
    J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human C5a induces a substantial histamine release in human basophils but not in tissue mast cells.
    Jürgensen H; Braam U; Pult P; Kownatzki E; Schmutzler W
    Int Arch Allergy Appl Immunol; 1988; 85(4):487-8. PubMed ID: 2451646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation.
    Mochizuki A; McEuen AR; Buckley MG; Walls AF
    J Allergy Clin Immunol; 2003 Jul; 112(1):102-8. PubMed ID: 12847486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.